Research
Molecular
The engineered GLP-1 receptor agonist depot offers a more convenient and long-lasting therapeutic option for managing diabetes and treating metabolic disorders.
This approach could simplify treatment regimens for patients with diabetes.
StrongSupportsmedium confidence
The formation of supramolecular nanofiber depots offers a more convenient and long-lasting therapeutic option to manage diabetes and treat metabolic disorders.
Why this rating
Based on the innovative approach to therapy described in the abstract.
Source
Engineering Supramolecular Nanofiber Depots from a Glucagon-Like Peptide-1 Therapeutic
Weike Chen et al. · ACS Nano · 2024
otherCited 6×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →